RPRX
Royalty Pharma plc · Healthcare
EVP and CFO Terrance P. Coyne sold $1.7M of Royalty Pharma plc
Sold$1,731,840
$49.78Price
34,791Shares
−28%Stake
What RPRX did after the filing
- The stock from Fri, May 1 open, $49.70
- +9.2%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jun 15 close.
Traded Tue, Apr 28. Filed Thu, Apr 30, 5:54 PM ET, after the close. Returns use the May 1 open and the Jun 15 close. Not investment advice.